Cite
HARVARD Citation
Havens, P. et al. (2017). Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis. Clinical infectious diseases. pp. 317-325. [Online].